Our Pharmaceuticals business is divided into six core areas, Cardiovascular & Metabolism; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension. We seek innovation across all of these areas where there is significant unmet patient need.
CLICK a circle below to see the diseases we are targeting.
Metabolism, Retinal Diseases, ThrombosisCardiovascular and Metabolism
Gastroenterology, Rheumatology - IL-23 PathwayImmunology
Hepatitis, Respiratory Infections, Bacterial & Viral VaccinesInfectious
Diseases and Vaccines
Mood Disorders, Neurodegenerative Disorders, Schizophrenia, Glutamatergic Pathway DiseasesNeuroscience
Prostate Cancer, Solid Tumor Targeted Therapy, Immuno-Oncology, Hematologic MalignanciesOncology
Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension (CTEPH)Pulmonary Hypertension
Johnson & Johnson Innovation is comprised of a family of complementary teams that bring meaningful solutions and flexible approaches to support collaboration. From incubation facilities to early-stage investing – from venture funding to acquisition, our teams offer partners a full range of capabilities.
Make the Connection
We look forward to our first discussion. If you would like to discuss a collaboration,
please connect with us and we will schedule a call soon.